NEWTOWN, Pa.--(BUSINESS WIRE)--Onconova Therapeutics, Inc. today announced the presentation of four scientific studies relating to its lead anticancer drug ON 01910.Na and new sulfonamide anticancer compounds at the Annual Meeting of the American Association for Cancer Research (AACR), held April 12-16, 2008 in San Diego.
